Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coconut refers to the fruit of the coconut palm (*Cocos nucifera*), which is utilized in various forms—most notably coconut oil, coconut water, and coconut sap—for therapeutic and nutritional purposes. In clinical research, Virgin Coconut Oil (VCO) is investigated for its antimicrobial, anti-inflammatory, and immunomodulatory properties, largely attributed to its high content of medium-chain fatty acids like lauric acid. It is studied across diverse indications, including COVID-19, periodontal disease, skin barrier protection in neonates, and wound healing. Coconut water is evaluated for hydration and metabolic effects, while coconut sap powder is researched for cardiovascular benefits such as lowering arterial stiffness. Additionally, coconut oil is a key component of specialized intravenous lipid emulsions used in parenteral nutrition to provide essential fatty acids and metabolic support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on coconut.